Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glutamate-ammonia ligase (glutamine synthetase) pseudogene 1 (GLULP1)
- Target
- GLULP1
- Molecular classification
- Pseudogene, Processed pseudogene, Non-coding RNA (potential for lncRNA production)
01
Overview
GLULP1, or glutamate-ammonia ligase (glutamine synthetase) pseudogene 1, is a processed pseudogene derived from the active GLUL gene, which encodes glutamine synthetase. Unlike GLUL, which catalyzes the conversion of glutamate and ammonia to glutamine, GLULP1 is non-coding due to accumulated mutations and is not translated into a functional enzyme. Some pseudogenes have regulatory functions at the RNA level or can modulate gene expression, but GLULP1, specifically, is currently only annotated as a pseudogene with no described protein product or biological activity. Its sequence is located on chromosome 5q33, and it may be transcribed as a non-coding RNA, but direct biological functions, disease associations, or clinical relevance are not established at present.
- Other names
- GLULP1glutamate-ammonia ligase pseudogene 1GLULL1glutamate-ammonia ligase (glutamine synthetase)-like 1glutamate-ammonia ligase (glutamine synthetase) pseudogene 1GLUL-like 1
02
Mechanism of action
There are no mechanisms of drug action for this pseudogene.
03
Biological functions
Genome regulation (potential as non-coding RNA, e.g., lncRNA, RNA regulators)Gene expression modulation via RNA interference or miRNA competition (possible, but specific functions for GLULP1 currently uncharacterized)No direct catalytic or receptor activity
04
Disease associations
No established direct roles in disease for GLULP1Pseudogene expression in general may have biomarker/prognostic utility or roles in cancer regulatory networks, but no evidence currently for GLULP1 specifically
Beyond the preview
Go deeper on Glutamate-ammonia ligase (glutamine synthetase) pseudogene 1 (GLULP1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Glutamate-ammonia ligase (glutamine synthetase) pseudogene 1 (GLULP1).